FDA Press Releases – What They Say – First Half 2014

From time to time, I field questions centered around FDA press releases and what they say.  Every time I would have to go hunt and peck through years of releases to get an answer. Eventually I just put them into a data base so that I could track them categorically and end the scavenger hunt.  In February of this year after completing it, I posted a review of the previous year’s releases and what they said and there was a good deal of interest in it – so here is an update looking at the first six months of 2014 – which I can scarcely believe are already over.

What does the agency that oversees the regulation of one-quarter of the U.S. economy have to say for itself? Here is an overview by subject matter:

To put that in context, the chart below compares the first six months of 2013 with the first six months of 2014.  A few bullet points of observations:

  • There were slightly fewer releases in the first half of 2014 compared to last year;
  • There was a significant drop in the numbers of releases related to drugs and an increase in those referring to devices;
  • There were slightly fewer announcements regarding approvals – 44 in 2013 compared to 40 in 2014, but perhaps more interesting was the fact that last year nearly 80% of approval announcement involved drugs while this year that dropped to 63%.  Correspondingly, last year by this time there were 8 device approvals announced – a number which has nearly doubled to 15 for this year.
  • There have been slightly fewer public health alerts and far fewer recalls, but there has been a slight increase in the numbers of new rules and guidances that were announced.

Here it is strictly by the numbers:

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Useful Resources. Bookmark the permalink.